Ironwood Pharmaceuticals IRWD Total costs & expenses

Total costs & expenses at other companies

Bausch Health CompaniesBHC

$3.47B+75.2%

ArdelyxARDX

$133.3M+19.0%

Rigel PharmaceuticalsRIGL

$46.93M+15.7%

Ionis PharmaceuticalsIONS

$370.24M+18.6%

Rhythm Pharmaceuticals, Inc.RYTM

$112.47M+41.1%

Neurocrine BiosciencesNBIX

——

FAQ

What is Ironwood Pharmaceuticals's total costs & expenses?

Ironwood Pharmaceuticals (IRWD) reported total costs & expenses of $33.73M in Q2 2026.

How has Ironwood Pharmaceuticals's total costs & expenses changed year-over-year?

Ironwood Pharmaceuticals's total costs & expenses decreased by 15.5% year-over-year, from $39.92M to $33.73M.

What is the long-term trend for Ironwood Pharmaceuticals's total costs & expenses?

Over 4 years (2021 to 2025), Ironwood Pharmaceuticals's total costs & expenses has grown at a 2.2% compound annual growth rate (CAGR), from $181.49M to $197.65M.

What does total costs & expenses mean?

This metric aggregates all operating and non-operating costs incurred by the company to generate revenue during a specific period. It includes the sum of cost of goods sold, research and development, and selling, general, and administrative expenses. Analyzing this figure helps investors evaluate the company's overall cost structure and operational discipline in relation to its top-line performance.